Page last updated: 2024-08-16

rizatriptan and rofecoxib

rizatriptan has been researched along with rofecoxib in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Barbosa, JS; Krymchantowski, AV	1
Bigal, ME; Krymchantowski, AV	1

Trials

2 trial(s) available for rizatriptan and rofecoxib

Article	Year
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:4 Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines	2002
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC neurology, 2004, Jun-28, Volume: 4 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; ortho-Aminobenzoates; Secondary Prevention; Serotonin Receptor Agonists; Sulfones; Treatment Outcome; Triazoles; Tryptamines	2004

Article

Year

Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.

Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:4

Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines

2002

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.

BMC neurology, 2004, Jun-28, Volume: 4

Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; ortho-Aminobenzoates; Secondary Prevention; Serotonin Receptor Agonists; Sulfones; Treatment Outcome; Triazoles; Tryptamines

2004

Other Studies

2 other study(ies) available for rizatriptan and rofecoxib

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008